Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-2017

Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-2017
复制标题

DOI:
10.3201/eid2509.190040
复制
发表时间:
2019-09-01
影响因子:
11.8
通讯作者:
Shilubane, Amanda
Shilubane, Amanda
中科院分区:
医学2区
文献类型:
--
作者:
van Schalkwyk, Erika;Mpembe, Ruth S.;Shilubane, Amanda

文献摘要

被引文献

相似文献

耳念珠菌是一种侵袭性的卫生保健相关真菌病原体。2016-2017年期间,南非通过国家实验室监测发现了念珠菌病病例,念珠菌病被定义为从血液中培养念珠菌的患者的疾病。我们通过质谱和测序鉴定了活菌。269家医院6669例病例(有种属鉴定的5876例)中,794例(14%)由金黄色葡萄球菌引起。133家医院所有念珠菌的发病率风险为83.8例/10万例(95% CI 81.2-86.4)。与其他念珠菌引起的血液感染相比,先前的全身抗真菌药物治疗与耳念珠菌真菌血症的校正几率增加40%相关(校正优势比为1.4 [95% CI 0.8-2.3])。粗住院病死率在不同念珠菌种类之间没有差异,耳念珠菌为45%,而非念珠菌为43%。奥瑞丝candidemia。锥虫引起了南非念珠菌病的重大流行病学转变。
Candida auris is an invasive healthcare-associated fungal pathogen. Cases of candidemia, defined as illness in patients with Candida cultured from blood, were detected through national laboratory-based surveillance in South Africa during 2016-2017. We identified viable isolates by using mass spectrometry and sequencing. Among 6,669 cases (5,876 with species identification) from 269 hospitals, 794 (14%) were caused by C. auris. The incidence risk for all candidemia at 133 hospitals was 83.8 (95% CI 81.2-86.4) cases/100,000 admissions. Prior systemic antifungal drug therapy was associated with a 40% increased adjusted odds of C. auris fungemia compared with bloodstream infection caused by other Candida species (adjusted odds ratio 1.4 [95% CI 0.8-2.3]). The crude in-hospital case-fatality ratio did not differ between Candida species and was 45% for C. auris candidemia, compared with 43% for non-C. auris candidemia. C. awls has caused a major epidemiologic shift in candidemia in South Africa.